Literature DB >> 11073113

Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages.

X Peng1, D M Mosser, M W Adler, T J Rogers, J J Meissler, T K Eisenstein.   

Abstract

In this study we investigated the capacity of morphine to modulate expression of cytokines in peritoneal macrophages. Mice were implanted subcutaneously with a 75-mg morphine slow-release pellet, and 48 h later resident peritoneal macrophages were harvested. Control groups received placebo pellets, naltrexone pellets, or morphine plus naltrexone pellets. Adherent cells were stimulated with lipopolysaccharide (LPS: 10 microg/mL) plus interferon-gamma (IFN-gamma: 100 units/mL) to induce cytokine production. After 24 h RNA was extracted for analysis of cytokine mRNA levels by reverse transcriptase-polymerase chain reaction, or supernatants were collected after 48 h for determination of cytokine production by enzyme-linked immunosorbent assay (ELISA). Morphine enhanced mRNA expression of interleukin (IL)-12 p40 and tumor necrosis factor alpha (TNF-alpha) compared with controls, whereas IL-10 levels were unchanged by drug treatment. ELISA data showed that both IL-12 p40 and p70 were increased by morphine. The enhancement of IL-12 at both the mRNA and protein levels was antagonized by naltrexone, indicating that the modulation of this cytokine by morphine is via a classic opioid receptor. These results are particularly interesting in light of our previous observation that 48 h after morphine pellet implantation, the peritoneal cavity is colonized with gram-negative and other enteric bacteria. The enhancement of IL-12 by morphine might be related to morphine-induced sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073113

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  25 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Influence of endogenous opioid systems on T lymphocytes as assessed by the knockout of mu, delta and kappa opioid receptors.

Authors:  Ali G Karaji; David Reiss; Audrey Matifas; Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  J Neuroimmune Pharmacol       Date:  2011-09-22       Impact factor: 4.147

Review 3.  HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse.

Authors:  Kurt F Hauser; Nazira El-Hage; Anne Stiene-Martin; William F Maragos; Avindra Nath; Yuri Persidsky; David J Volsky; Pamela E Knapp
Journal:  J Neurochem       Date:  2006-12-01       Impact factor: 5.372

Review 4.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

5.  Chronic morphine consumption increase allograft rejection rate in rat through inflammatory reactions.

Authors:  Ali Rafati; Sommaye Hamzehie Taj; Negar Azarpira; Assadollah Zarifkar; Ali Noorafshan; Parvaneh Najafizadeh
Journal:  Iran Biomed J       Date:  2011

6.  Morphine treatment of human monocyte-derived macrophages induces differential miRNA and protein expression: impact on inflammation and oxidative stress in the central nervous system.

Authors:  Rajnish S Dave; Kamel Khalili
Journal:  J Cell Biochem       Date:  2010-07-01       Impact factor: 4.429

7.  Morphine reciprocally regulates IL-10 and IL-12 production by monocyte-derived human dendritic cells and enhances T cell activation.

Authors:  Davorka Messmer; Ikusuke Hatsukari; Naoko Hitosugi; Ingo G H Schmidt-Wolf; Pravin C Singhal
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

8.  Therapy with the opioid antagonist naltrexone promotes mucosal healing in active Crohn's disease: a randomized placebo-controlled trial.

Authors:  Jill P Smith; Sandra I Bingaman; Francesca Ruggiero; David T Mauger; Aparna Mukherjee; Christopher O McGovern; Ian S Zagon
Journal:  Dig Dis Sci       Date:  2011-03-08       Impact factor: 3.199

Review 9.  Molecular targets of opiate drug abuse in neuroAIDS.

Authors:  K F Hauser; N El-Hage; S Buch; J R Berger; W R Tyor; A Nath; A J Bruce-Keller; P E Knapp
Journal:  Neurotox Res       Date:  2005-10       Impact factor: 3.911

Review 10.  Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression.

Authors:  M J Finley; C M Happel; D E Kaminsky; T J Rogers
Journal:  Cell Immunol       Date:  2008-02-14       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.